Quitting produces benefits that begin almost immediately
En Colombia, el humo del cigarrillo sigue siendo la causa más prevenible de muerte prematura, manifestándose con mayor crueldad en la enfermedad pulmonar obstructiva crónica, que hoy ocupa el tercer lugar entre las causas de fallecimiento en el país. Cuatro millones de colombianos fuman, y cada año 35.000 de sus compatriotas mueren por enfermedades ligadas al tabaco, una cifra que no refleja fatalidad inevitable sino decisiones colectivas que aún pueden revertirse. La ciencia ofrece un contrapeso esperanzador: el cuerpo humano comienza a sanar casi en el instante en que se apaga el último cigarrillo.
- La EPOC avanza en silencio y sin piedad: el 12,1% de los colombianos mayores de 40 años ya la padece, una prevalencia que creció un 36% en apenas dos décadas.
- El tabaco no destruye solo los pulmones —arrastra consigo enfermedades cardíacas, accidentes cerebrovasculares y más de diez tipos de cáncer, convirtiendo el hábito en una crisis de salud pública multidimensional.
- El peso económico agrava el daño físico: un fumador de una cajetilla diaria gasta cerca de 4,3 millones de pesos al año solo en cigarrillos, sin contar tratamientos médicos ni seguros más costosos.
- La respuesta institucional se intensifica con programas de cesación y prevención, apostando por la educación sostenida como el instrumento más poderoso para romper el ciclo.
- La esperanza es concreta y medible: a los tres meses de dejar de fumar, la función pulmonar mejora hasta un 10%; al año, el riesgo cardiovascular cae de forma significativa.
El 25 de mayo, Día Mundial sin Tabaco, expertos en salud presentaron cifras que retratan con dureza el costo humano del cigarrillo en Colombia. Aproximadamente cuatro millones de colombianos fuman —el 7,5% de la población—, y el tabaco cobra cada año unas 35.000 vidas en el país. La enfermedad pulmonar obstructiva crónica, que destruye la capacidad respiratoria de forma progresiva y a menudo pasa desapercibida hasta que el daño es severo, se ha convertido en la tercera causa de muerte nacional. El estudio Prepocol II reveló que su prevalencia entre mayores de 40 años alcanza el 12,1%, un salto del 36% en veinte años.
El vínculo entre tabaco y EPOC es directo: el 40% de los casos en Colombia se atribuye al consumo de cigarrillos. Pero el daño no se detiene en los pulmones. El tabaco alimenta también enfermedades del corazón, derrames cerebrales y más de diez tipos de cáncer, golpeando con más fuerza a quienes ya cargan con enfermedades respiratorias crónicas. A escala global, en 2024 unos 1.300 millones de personas consumían productos de tabaco, y el hábito seguía matando cerca de siete millones al año.
Sin embargo, la evidencia médica ofrece un camino claro. A las 24 horas de dejar de fumar, el monóxido de carbono en sangre comienza a normalizarse. A los tres meses, los pulmones recuperan parte de su capacidad de limpieza y la función pulmonar puede mejorar hasta un 10%. Al año, los riesgos cardiovasculares caen de manera notable. Mónica Olmos, directora médica de salud respiratoria en GSK, subrayó que prevenir la EPOC exige no solo evitar el tabaco, sino acompañar activamente a quienes quieren dejarlo. El argumento económico refuerza el sanitario: un fumador de una cajetilla diaria destina alrededor de 4,3 millones de pesos anuales solo al cigarrillo, sin contar los costos médicos derivados.
Las autoridades sanitarias colombianas intensifican sus programas de prevención y cesación, convencidas de que el tabaco, siendo el principal motor de las muertes por EPOC, es también el factor más controlable. Cada persona que deja de fumar es una vida que escapa de una estadística que no tenía por qué existir.
Cigarette smoke has become one of the most persistent threats to public health in Colombia, and nowhere is that clearer than in the rising toll of chronic obstructive pulmonary disease. On May 25th, as the world marked the day dedicated to smoking cessation, health experts released figures that underscored a grim reality: roughly four million Colombians smoke in some form, representing 7.5 percent of the national population. The consequence is stark—approximately 35,000 people die each year from diseases tied to tobacco use, making smoking one of the country's most preventable killers.
COPD, the progressive lung disease that makes breathing increasingly difficult, now ranks as Colombia's third leading cause of death. Globally, the picture is no less alarming. In 2024, about 1.3 billion people worldwide used tobacco products, and the habit continued to claim roughly seven million lives annually. The disease itself destroys lung function gradually, limiting what people can do in their daily lives and often going undiagnosed until significant damage has already occurred. A study called Prepocol II revealed that among Colombians over 40, the prevalence of COPD has reached 12.1 percent—a 36 percent jump over the past two decades.
The link between smoking and COPD is direct and measurable. About 40 percent of all COPD cases in Colombia trace directly to cigarette consumption. But tobacco's damage extends far beyond the lungs. Smoking also drives heart disease, stroke, and more than ten varieties of cancer, each one chipping away at years of life and quality of living. The burden falls heaviest on those already struggling with respiratory illness, who find themselves trapped in a cycle of worsening symptoms and limited options.
Yet there is reason for cautious hope. Medical experts emphasize that quitting smoking produces benefits that begin almost immediately. Within 24 hours of the last cigarette, carbon monoxide levels in the blood start to normalize and the body begins its recovery. Three months in, the lungs regain some of their natural cleaning ability, and lung function can improve by as much as 10 percent. A year without smoking brings even more substantial gains—cardiovascular complications drop significantly, breathing capacity improves, and the risk of further deterioration slows. The benefits extend to those around the smoker too, reducing secondhand smoke exposure and its associated harms.
Mónica Olmos, a medical director overseeing respiratory health at GSK, stressed that preventing diseases like COPD means more than just avoiding cigarettes—it means actively supporting people who want to quit and promoting the habits that keep lungs healthy. She noted that education and sustained support can transform the lives of millions. The economic argument adds another layer. A Colombian who smokes a pack a day spends roughly 4.3 million pesos annually on cigarettes alone, not counting the cost of lighters, medical treatments for smoking-related illnesses, or higher insurance premiums. Quitting, then, is not just a health decision but a financial one.
Health officials across the country are pushing harder on prevention and cessation programs, recognizing them as among the most effective tools available in public health. The message is straightforward: smoking remains the dominant driver of COPD deaths in Colombia, but it is also the most controllable one. Every person who quits is one fewer statistic, one more person who might breathe easier and live longer.
Notable Quotes
Preventing respiratory diseases like COPD means protecting the ability to breathe better and live better—promoting education, fostering healthy habits, and supporting those who want to quit can transform the quality of life for millions.— Mónica Olmos, medical director of respiratory health at GSK
The Hearth Conversation Another angle on the story
Why does COPD matter so much in Colombia specifically? It's the third leading cause of death—that's significant, but what makes it different from other countries?
The prevalence has exploded. In just twenty years, cases among people over 40 jumped 36 percent. That's not gradual drift—that's acceleration. And because smoking is so directly tied to it, you're looking at a disease that's largely preventable but increasingly common.
So if 40 percent of COPD cases come from smoking, what about the other 60 percent?
Air pollution, occupational exposure, genetics, aging—those all play a role. But the point experts keep making is that the 40 percent tied to tobacco is the part we can actually control right now. That's where the intervention matters most.
The economic angle is interesting. Four million smokers, 35,000 deaths a year. Does quitting actually stick for people, or is it mostly a temporary thing?
The source doesn't address relapse rates, but it does emphasize that the benefits are real and measurable. Within three months you see lung function improve by 10 percent. That's not theoretical—that's something a person can feel. That might be what keeps someone going.
What about the people who are already sick with COPD? Can quitting still help them?
Absolutely. The disease is progressive, but stopping smoking slows that progression. You're not curing it, but you're buying time and quality of life. That matters enormously when you're already struggling to breathe.
Is there a sense that Colombia is actually moving on this, or is it still mostly warnings?
The article mentions strengthening prevention and cessation strategies, and they're marking World No Tobacco Day with data releases. That suggests some momentum, but 35,000 deaths a year is still the baseline. The real test is whether those strategies actually reach the four million smokers who need them.